Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.123, Iss.2, 2010-09, pp. : 611-612

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

By Pierce Lori

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 389-398

Springer Publishing Company

Access to resources Recommend Favorite

The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

By Kaufman Bella

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 521-527

Springer Publishing Company

Access to resources Recommend Favorite

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 241-242

Informa Healthcare

Access to resources Recommend Favorite

Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

By Kotsopoulos Joanne

Cancer Causes and Control, Vol. 16, Iss. 6, 2005-08 ,pp. : 667-674

Springer Publishing Company

Access to resources Recommend Favorite

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 315-316

Informa Healthcare

Access to resources Recommend Favorite